• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清护骨素水平与腹膜透析患者外周动脉疾病呈正相关。

Serum osteoprotegerin level is positively associated with peripheral artery disease in patients with peritoneal dialysis.

机构信息

Division of Nephrology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.

School of Medicine, Tzu Chi University, Hualien, Taiwan.

出版信息

Ren Fail. 2020 Nov;42(1):131-136. doi: 10.1080/0886022X.2020.1714654.

DOI:10.1080/0886022X.2020.1714654
PMID:31950864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7006676/
Abstract

Osteoprotegerin (OPG) is a potential biomarker of cardiovascular disease complications and severity. Peripheral arterial disease (PAD) is associated with an increased risk of death in patients on peritoneal dialysis (PD). Therefore, this study aimed to evaluate the relationship between serum OPG levels and PAD by measuring the ankle-brachial index (ABI) of patients on PD. A commercial enzyme-linked immunosorbent assay kit was used to measure OPG values. Left or right ABI values of <0.9 were categorized as the low ABI group. Among 70 patients on PD, 13 (18.6%) were categorized in the low ABI group. Patients in the low ABI group had higher prevalence of diabetes mellitus ( = .044) and higher serum C-reactive protein (CRP) ( < .001) and OPG levels ( < .001) but lower creatinine ( = .013) and peritoneal Kt/V ( = .048) levels than those in the normal ABI group. Results of multivariable logistic regression analysis revealed that OPG [adjusted odds ratio (aOR) 1.027, 95% confidence interval (CI) 1.010-1.045,  = .002] and CRP (aOR 1.102, 95% CI 1.006-1.207,  = .037) levels were independent predictors of PAD in patients on PD. OPG can also be used to predict PAD development with the area under the receiver operating characteristic curve of 0.823 (95% CI: 0.714-0.904,  < .001) in patients on PD. Therefore, serum OPG and CRP levels can be considered as risk factors for PAD development in patients on PD.

摘要

骨保护素 (OPG) 是心血管疾病并发症和严重程度的潜在生物标志物。周围动脉疾病 (PAD) 与腹膜透析 (PD) 患者的死亡风险增加有关。因此,本研究旨在通过测量 PD 患者的踝臂指数 (ABI) 来评估血清 OPG 水平与 PAD 之间的关系。使用商业酶联免疫吸附测定试剂盒测量 OPG 值。ABI 值 <0.9 的左或右 ABI 被归类为低 ABI 组。在 70 名 PD 患者中,有 13 名 (18.6%) 被归类为低 ABI 组。低 ABI 组患者糖尿病患病率更高( = .044),血清 C 反应蛋白 (CRP)( < .001)和 OPG 水平( < .001)更高,但肌酐( = .013)和腹膜 Kt/V( = .048)水平更低与正常 ABI 组相比。多变量逻辑回归分析结果显示,OPG [调整优势比 (aOR) 1.027,95%置信区间 (CI) 1.010-1.045,  = .002] 和 CRP (aOR 1.102,95% CI 1.006-1.207,  = .037) 水平是 PD 患者 PAD 的独立预测因素。OPG 也可用于预测 PD 患者 PAD 发展,曲线下面积为 0.823(95% CI:0.714-0.904,  < .001)。因此,血清 OPG 和 CRP 水平可被视为 PD 患者 PAD 发展的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf1e/7006676/3b6148a7e5c7/IRNF_A_1714654_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf1e/7006676/3b6148a7e5c7/IRNF_A_1714654_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf1e/7006676/3b6148a7e5c7/IRNF_A_1714654_F0001_B.jpg

相似文献

1
Serum osteoprotegerin level is positively associated with peripheral artery disease in patients with peritoneal dialysis.血清护骨素水平与腹膜透析患者外周动脉疾病呈正相关。
Ren Fail. 2020 Nov;42(1):131-136. doi: 10.1080/0886022X.2020.1714654.
2
Risk Factors for Development of PAD in PD Patients.帕金森病患者发生外周动脉疾病的危险因素。
Iran J Kidney Dis. 2021 Jan;15(1):56-60.
3
Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes.2型糖尿病患者中骨保护素与外周动脉疾病的关联
Arch Cardiovasc Dis. 2015 Aug-Sep;108(8-9):412-9. doi: 10.1016/j.acvd.2015.01.015. Epub 2015 Jul 13.
4
Association of serum osteoprotegerin with ankle-brachial index and urine albumin: creatinine ratio in African-Americans and non-Hispanic whites.非裔美国人和非西班牙裔白人血清骨保护素与踝臂指数及尿白蛋白:肌酐比值的关联
Atherosclerosis. 2009 Oct;206(2):575-80. doi: 10.1016/j.atherosclerosis.2009.03.032. Epub 2009 Apr 5.
5
Elevated serum osteoprotegerin may predict peripheral arterial disease after kidney transplantation: a single-center prospective cross-sectional study in Taiwan.血清骨保护素升高可能预测肾移植后的外周动脉疾病:台湾一项单中心前瞻性横断面研究
PeerJ. 2017 Oct 2;5:e3847. doi: 10.7717/peerj.3847. eCollection 2017.
6
Subclinical peripheral artery disease in patients undergoing peritoneal dialysis: risk factors and outcome.接受腹膜透析患者的亚临床外周动脉疾病:危险因素与结局
Perit Dial Int. 2009 Jan-Feb;29(1):64-71.
7
Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects.血清高迁移率族蛋白 B1 和护骨素水平与 2 型糖尿病患者的外周动脉疾病和肢体严重缺血相关。
Cardiovasc Diabetol. 2017 Aug 8;16(1):99. doi: 10.1186/s12933-017-0581-z.
8
Osteoprotegerin concentration is associated with the presence and severity of peripheral arterial disease in type 2 diabetes mellitus.骨保护素浓度与2型糖尿病患者外周动脉疾病的存在及严重程度相关。
Vasa. 2018 Feb;47(2):131-135. doi: 10.1024/0301-1526/a000682. Epub 2018 Jan 9.
9
High serum resistin levels are associated with peripheral artery disease in the hypertensive patients.高血压患者血清抵抗素水平升高与外周动脉疾病相关。
BMC Cardiovasc Disord. 2017 Mar 15;17(1):80. doi: 10.1186/s12872-017-0517-2.
10
Elevated osteoprotegerin is associated with inflammation, malnutrition and new onset cardiovascular events in peritoneal dialysis patients.骨保护素水平升高与腹膜透析患者的炎症、营养不良和新发心血管事件有关。
Atherosclerosis. 2011 Dec;219(2):925-30. doi: 10.1016/j.atherosclerosis.2011.09.025. Epub 2011 Sep 21.

引用本文的文献

1
High Serum Galectin-3 Level as a Potential Biomarker of Peripheral Artery Disease in Patients Undergoing Hemodialysis.高血清半乳糖凝集素-3水平作为接受血液透析患者外周动脉疾病的潜在生物标志物。
Rev Cardiovasc Med. 2024 Mar 29;25(4):124. doi: 10.31083/j.rcm2504124. eCollection 2024 Apr.
2
The Relationship Between Bone Metabolism and Peripheral Artery Disease in Patients on Hemodialysis: The Potential Role of Osteocalcin.血液透析患者骨代谢与外周动脉疾病之间的关系:骨钙素的潜在作用
Diabetes Metab Syndr Obes. 2023 Oct 26;16:3331-3337. doi: 10.2147/DMSO.S432345. eCollection 2023.
3
Serum Osteoprotegerin Levels and the Vascular Reactivity Index in Patients with Hypertension.

本文引用的文献

1
National and subnational estimation of the prevalence of peripheral artery disease (PAD) in China: a systematic review and meta-analysis.中国外周动脉疾病(PAD)患病率的国家和次国家估计:系统评价和荟萃分析。
J Glob Health. 2019 Jun;9(1):010601. doi: 10.7189/jogh.09.010601.
2
Elevated serum osteoprotegerin may predict peripheral arterial disease after kidney transplantation: a single-center prospective cross-sectional study in Taiwan.血清骨保护素升高可能预测肾移植后的外周动脉疾病:台湾一项单中心前瞻性横断面研究
PeerJ. 2017 Oct 2;5:e3847. doi: 10.7717/peerj.3847. eCollection 2017.
3
The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases.
高血压患者的血清护骨素水平与血管反应指数。
Medicina (Kaunas). 2023 Oct 9;59(10):1794. doi: 10.3390/medicina59101794.
4
Association of Circulating Osteoprotegerin Level with Blood Pressure Variability in Patients with Chronic Kidney Disease.慢性肾脏病患者循环骨保护素水平与血压变异性的关联
J Clin Med. 2021 Dec 29;11(1):178. doi: 10.3390/jcm11010178.
5
Serum Osteoprotegerin Level Is Negatively Associated with Bone Mineral Density in Patients Undergoing Maintenance Hemodialysis.维持性血液透析患者的血清护骨素水平与骨密度呈负相关。
Medicina (Kaunas). 2021 Jul 27;57(8):762. doi: 10.3390/medicina57080762.
骨保护素在血管和骨骼之间相互作用中的作用:作为代谢性心血管疾病标志物的潜在用途。
Pharmacol Ther. 2018 Feb;182:115-132. doi: 10.1016/j.pharmthera.2017.08.015. Epub 2017 Sep 1.
4
Osteoprotegerin Is the Strongest Predictor for Progression of Arterial Calcification in Peritoneal Dialysis Patients.骨保护素是腹膜透析患者动脉钙化进展的最强预测指标。
Am J Nephrol. 2017;46(1):39-46. doi: 10.1159/000477380. Epub 2017 Jun 15.
5
High serum resistin levels are associated with peripheral artery disease in the hypertensive patients.高血压患者血清抵抗素水平升高与外周动脉疾病相关。
BMC Cardiovasc Disord. 2017 Mar 15;17(1):80. doi: 10.1186/s12872-017-0517-2.
6
Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study.影响慢性肾脏病谱中踝臂指数病理值的因素:NEFRONA 研究。
Nephrol Dial Transplant. 2017 Mar 1;32(3):513-520. doi: 10.1093/ndt/gfw039.
7
Serum Osteoprotegerin Levels Related With Cardiovascular Risk Factors in Chronic Kidney Disease.慢性肾脏病中血清骨保护素水平与心血管危险因素的关系
J Clin Lab Anal. 2016 Nov;30(6):811-817. doi: 10.1002/jcla.21941. Epub 2016 Mar 17.
8
Association of plasma osteoprotegerin levels with the severity of lower extremity arterial disease in patients with type 2 diabetes.2型糖尿病患者血浆骨保护素水平与下肢动脉疾病严重程度的关联
BMC Cardiovasc Disord. 2015 Aug 11;15:86. doi: 10.1186/s12872-015-0079-0.
9
Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes.2型糖尿病患者中骨保护素与外周动脉疾病的关联
Arch Cardiovasc Dis. 2015 Aug-Sep;108(8-9):412-9. doi: 10.1016/j.acvd.2015.01.015. Epub 2015 Jul 13.
10
Hemodialysis Is Associated With Increased Peripheral Artery Occlusive Disease Risk Among Patients With End-Stage Renal Disease: A Nationwide Population-Based Cohort Study.血液透析与终末期肾病患者外周动脉闭塞性疾病风险增加相关:一项基于全国人口的队列研究。
Medicine (Baltimore). 2015 Jul;94(28):e1164. doi: 10.1097/MD.0000000000001164.